WE HAVE 2 NEW TYSABRI EDITORS STARTING 4/15/10! THEY WIL BE POSTING TYSABRI NEWS EVERY DAY!
Thursday, October 27
Biogen Idec profits drop 26%
MORE- The Boston Globe: "Biogen Idec's withdrawal of multiple sclerosis drug Tysabri has forced the company to rely on older drugs to bolster earnings.
